Cellosaurus ALL-SIL (CVCL_1805)

Cell line name ALL-SIL
Synonyms ALLSIL; SIL-ALL
Accession CVCL_1805
Resource Identification Initiative To cite this cell line use: ALL-SIL (RRID:CVCL_1805)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Doubling time: 64 hours (PubMed=17117183); ~48 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Misspelling: AL:L-SIL; In Cosmic 913404.
Derived from sampling site: Peripheral blood.
Disease Childhood T acute lymphoblastic leukemia (NCIt: C7953)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ

Markers:
AmelogeninX,Y
CSF1PO10,12
D13S3179,12
D16S53910,12
D5S81811,13
D7S82011,12
TH017,9.3
TPOX10,11
vWA17
Publications

PubMed=10071127; DOI=10.1016/S0145-2126(98)00146-5
Kawamura M., Ohnishi H., Guo S.X., Sheng X.M., Minegishi M., Hanada R., Horibe K., Hongo T., Kaneko Y., Bessho F., Yanagisawa M., Sekiya T., Hayashi Y.
Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Leuk. Res. 23:115-126(1999)

PubMed=17117183; DOI=10.1038/sj.bjc.6603447
Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J., Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.
Br. J. Cancer 95:1537-1544(2006)

PubMed=22675565; DOI=10.1371/journal.pone.0038463
Kalender Atak Z., De Keersmaecker K., Gianfelici V., Geerdens E., Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G., Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P., Cools J., Aerts S.
High accuracy mutation detection in leukemia on a selected panel of cancer genes.
PLoS ONE 7:E38463-E38463(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections DSMZ; ACC-511
Cell line databases/resources CCLE; ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cosmic-CLP; 1295740
GDSC; 1295740
LINCS_LDP; LCL-2059
Ontologies BTO; BTO:0005360
Biological sample resources BioSample; SAMN03473514
Gene expression databases GEO; GSM1669597
Polymorphism and mutation databases Cosmic; 721715
Cosmic; 913404
Cosmic; 933537
Cosmic; 996306
Cosmic; 998724
Cosmic; 1037687
Cosmic; 1115585
Cosmic; 1175126
Cosmic; 1224372
Cosmic; 1330498
Cosmic; 1524789
Cosmic; 1641391
Cosmic; 1664519
Cosmic; 1760517
Cosmic; 2165718
Cosmic; 2602907